Clinical Trial Update: Reduced Toxicity Conditioning Prior to Unrelated Cord Cell Transplantation for High Risk Myeloid Malignancies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating reduced toxicity conditioning before unrelated cord blood cell transplantation in high-risk myeloid malignancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia Myeloid

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Leukemia, Myeloid | Phase 2 | Status: UNKNOWN